BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 34986808)

  • 21. Chronic unilateral tearing as a sign of lacrimal sac squamous cell carcinoma.
    Matos AMF; Brega DR; Gollner AM; Gonçalves ACP
    Arq Bras Oftalmol; 2021; 84(6):602-605. PubMed ID: 34431882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lacrimal Fossa Bony Changes in Chronic Primary Acquired Nasolacrimal Duct Obstruction and Acute Dacryocystitis.
    Ali MJ; Mishra DK; Bothra N
    Curr Eye Res; 2021 Aug; 46(8):1132-1136. PubMed ID: 33583297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lacrimal Intrasaccal Polyp With Inspissated Mucopeptide Concretions.
    Ali MJ; Joshi A; Pattnaik M; Jakati S
    Ophthalmic Plast Reconstr Surg; 2021 Jul-Aug 01; 37(4):e145-e148. PubMed ID: 33587423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional metagenomic profile of the lacrimal sac microbial communities in primary acquired nasolacrimal duct obstruction: The Lacriome paper 2.
    Ali MJ
    Eur J Ophthalmol; 2022 Jul; 32(4):2059-2066. PubMed ID: 34816752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nasolacrimal duct obstruction caused by an oncocytoma.
    de Bree R; Scheeren RA; Kummer A; Tiwari RM
    Rhinology; 2002 Sep; 40(3):165-7. PubMed ID: 12357720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of sodium iodide symporter in the lacrimal drainage system: implication for the mechanism underlying nasolacrimal duct obstruction in I(131)-treated patients.
    Morgenstern KE; Vadysirisack DD; Zhang Z; Cahill KV; Foster JA; Burns JA; Kloos RT; Jhiang SM
    Ophthalmic Plast Reconstr Surg; 2005 Sep; 21(5):337-44. PubMed ID: 16234694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between lacrimal sac size and duration of tearing in nasolacrimal duct obstruction.
    Lee MJ; Kim IH; Choi YJ; Kim N; Choung HK; Khwarg SI
    Can J Ophthalmol; 2019 Feb; 54(1):111-115. PubMed ID: 30851763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High nasolacrimal sac-duct junction anatomical variation - retrospective review of dacryocystography images.
    Juniat V; Lee J; Sia P; Curragh D; Hardy TG; Selva D
    Orbit; 2021 Dec; 40(6):505-508. PubMed ID: 32893697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcanalicular endoscopic dacryoplasty in patients with primary acquired nasolacrimal duct obstruction.
    Lee SM; Lew H
    Graefes Arch Clin Exp Ophthalmol; 2021 Jan; 259(1):173-180. PubMed ID: 32743774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of Lacrimal Sac Massage in Management of Congenital Nasolacrimal Duct Obstruction in Infants: An Observational Study of 853 Cases from a Single Institute of Eastern Asia.
    Nanda D; Sarkar M
    Middle East Afr J Ophthalmol; 2022; 29(4):216-219. PubMed ID: 38162564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case report of chronic dacryocystitis caused by nasal stones.
    Huo Y; Li L; Mo Y; Guo S
    BMC Ophthalmol; 2023 Nov; 23(1):445. PubMed ID: 37926842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of indocyanine green gel in the identification and complete removal of the medial wall of the lacrimal sac during endoscopic endonasal dacryocystorhinostomy.
    Park J; Lee J; Lee H; Baek S
    Can J Ophthalmol; 2017 Oct; 52(5):494-498. PubMed ID: 28985810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of nasolacrimal duct obstruction in adults with polyurethane stent.
    Yazici B; Yazici Z; Parlak M
    Am J Ophthalmol; 2001 Jan; 131(1):37-43. PubMed ID: 11162977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of bacteriologic infection in the etiology of nasolacrimal duct obstruction.
    DeAngelis D; Hurwitz J; Mazzulli T
    Can J Ophthalmol; 2001 Apr; 36(3):134-9. PubMed ID: 11367584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Routine histopathologic evaluation of the lacrimal sac during dacryocystorhinostomy: how useful is it?
    Bernardini FP; Moin M; Kersten RC; Reeves D; Kulwin DR
    Ophthalmology; 2002 Jul; 109(7):1214-7; discussion 1217-8. PubMed ID: 12093640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lacrimal Duct Obstruction in Adults].
    Heichel J; Struck HG
    Klin Monbl Augenheilkd; 2021 Feb; 238(2):211-230. PubMed ID: 33207380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nasal and Lacrimal Sac Histopathology in Patients With Granulomatous Polyangiitis Undergoing Lacrimal Drainage Surgery.
    Stewart CM; Rose GE
    Ophthalmic Plast Reconstr Surg; 2020; 36(1):67-69. PubMed ID: 31593043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical profile and management outcomes of lacrimal drainage system malignancies.
    Alam MS; Mukherjee B; Krishnakumar S
    Orbit; 2022 Aug; 41(4):429-436. PubMed ID: 34018461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bilateral acquired nasolacrimal duct obstruction secondary to amyloidosis in a 15-year-old.
    Dermarkarian CR; Bhatt A; Chévez-Barrios P; Allen RC
    J AAPOS; 2021 Apr; 25(2):126-128. PubMed ID: 33652101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered Surfactant Protein Expression in Primary Acquired Nasolacrimal Duct Obstruction.
    Ali MJ; Bráuer L; Schicht M; Paulsen F
    Ophthalmic Plast Reconstr Surg; 2019; 35(6):553-557. PubMed ID: 30882588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.